Nearly half of nurses and physicians surveyed for a KLAS Arch Collaborative report expressed a likelihood leaving their current organization within two years, with 21% of nurses and 13% of physicians actually departing. According to…
Access to GLP-1 medications is improving as manufacturers, insurers, and policymakers address high demand, costs, and coverage challenges, Becker’s Hospital Review reported December 13. As detailed in the article, Eli Lilly’s partnership with telehealth company…
Perioperative immunotherapy is reshaping treatment strategies for early-stage non-small cell lung cancer (NSCLC) without actionable mutations, according to Dr. Roy S. Herbst of Yale Cancer Center. In a recent interview with OncLive, the oncology expert…